ArticleFrontiers in psychology2026
Associations between cognitive reserve, iron deposition in the basal ganglia, and cognitive function in mild cognitive impairment.
Article in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This research aims to investigate the putative mechanisms underlying the association between iron deposition and cognition in mild cognitive impairment (MCI). It also seeks to analyze whether the relationship between cognitive reserve (CR) and cognition may be mediated by iron deposition. Methods: In total, 109 individuals with MCI and 90 healthy controls (HCs) were enrolled to evaluate iron deposition in the basal ganglia using quantitative susceptibility mapping (QSM). The Cognitive Reserve Index questionnaire (CRIq) was used to evaluate the comprehensive CR of participants in both groups. QSM values in the basal ganglia were compared between the two groups, and Spearman correlation analyses were performed to examine the associations between CR, QSM values, and cognition. Mediation analyses using a bootstrapping approach were conducted to investigate the correlations between CR, QSM values, and cognition. Results: The MCI group exhibited significantly higher QSM values in the bilateral putamen (PU), substantia nigra (SN), red nucleus (RN), and right caudate nucleus (CA) compared to HCs. After adjusting for age and sex, QSM values in the left RN were negatively correlated with Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), Auditory Verbal Learning Test (AVLT) long-delay recall, and AVLT recognition scores. In contrast, QSM values in the bilateral RN and left SN were negatively correlated with Clock Drawing Test (CDT) scores in the MCI group. CRIq scores were significantly negatively correlated with QSM values in the bilateral RN and right SN. Meanwhile, QSM values in the bilateral RN partially mediated the association between the CRIq scores and cognition in the MCI group. Conclusion: Individuals with MCI who have different CR levels exhibited differences in iron deposition in the basal ganglia. Comprehensive CR may delay the decline of cognitive function by regulating iron deposition in the bilateral RN during the MCI stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.